TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.66% | -147.72% | -129.52% | -548.28% | 36.89% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.26% | 105.21% | 2,695.80% | 867.62% | -1,618.08% |
| Change in Net Operating Assets | -72.60% | -1,706.63% | 2,404.17% | 122.82% | 55.55% |
| Cash from Operations | 60.46% | -15.05% | 31.92% | 51.86% | 14.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.44% | -8.18% | -388.12% | 106.49% | 120.80% |
| Cash from Investing | -81.44% | -8.18% | -388.12% | 106.49% | 120.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | -- |
| Total Dividends Paid | 6.57% | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.20% | -- | -- | -108.68% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.78% | 220.93% | 427.77% | -338.07% | 442.51% |